| Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease S Romeo, J Kozlitina, C Xing, A Pertsemlidis, D Cox, LA Pennacchio, ... Nature genetics 40 (12), 1461, 2008 | 3475 | 2008 |
| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 1037 | 2023 |
| Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects LMS Carlsson, M Peltonen, S Ahlin, Å Anveden, C Bouchard, B Carlsson, ... New England Journal of Medicine 367 (8), 695-704, 2012 | 958 | 2012 |
| Genetics and epigenetics of NAFLD and NASH: Clinical impact M Eslam, L Valenti, S Romeo Journal of hepatology 68 (2), 268-279, 2018 | 887 | 2018 |
| Inclisiran for the treatment of heterozygous familial hypercholesterolemia FJ Raal, D Kallend, KK Ray, T Turner, W Koenig, RS Wright, ... New England Journal of Medicine 382 (16), 1520-1530, 2020 | 626 | 2020 |
| The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016 | 618 | 2016 |
| Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL S Romeo, LA Pennacchio, Y Fu, E Boerwinkle, A Tybjaerg-Hansen, ... Nature genetics 39 (4), 513-516, 2007 | 607 | 2007 |
| Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 557 | 2015 |
| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 536 | 2021 |
| Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans S Romeo, W Yin, J Kozlitina, LA Pennacchio, E Boerwinkle, HH Hobbs, ... The Journal of clinical investigation 119 (1), 70-79, 2009 | 479 | 2009 |
| Statin use and non-alcoholic steatohepatitis in at risk individuals P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ... Journal of hepatology 63 (3), 705-712, 2015 | 441 | 2015 |
| An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans A Mardinoglu, H Wu, E Bjornson, C Zhang, A Hakkarainen, SM Räsänen, ... Cell metabolism 27 (3), 559-571. e5, 2018 | 386 | 2018 |
| Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study C Levy-Marchal, CC Patterson, A Green, Eurodiab Ace Study Group Diabetologia 44, B75-B80, 2001 | 376 | 2001 |
| PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ... Human molecular genetics 23 (15), 4077-4085, 2014 | 372 | 2014 |
| Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver P Dongiovanni, S Stender, A Pietrelli, RM Mancina, A Cespiati, S Petta, ... Journal of internal medicine 283 (4), 356-370, 2018 | 299 | 2018 |
| Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro C Pirazzi, M Adiels, MA Burza, RM Mancina, M Levin, M Ståhlman, ... Journal of hepatology 57 (6), 1276-1282, 2012 | 298 | 2012 |
| PNPLA3 gene in liver diseases E Trépo, S Romeo, J Zucman-Rossi, P Nahon Journal of hepatology 65 (2), 399-412, 2016 | 272 | 2016 |
| PNPLA3 I148M polymorphism and progressive liver disease P Dongiovanni, B Donati, R Fares, R Lombardi, RM Mancina, S Romeo, ... World journal of gastroenterology: WJG 19 (41), 6969, 2013 | 269 | 2013 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017 | 244 | 2017 |
